- Home
- DIAX vs DNA Comparison
DIAX vs DNA Comparison
Compare DIAX & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DIAX
- DNA
- Stock Information
- Founded
- DIAX 2005
- DNA 2008
- Country
- DIAX United States
- DNA United States
- Employees
- DIAX N/A
- DNA N/A
- Industry
- DIAX Finance Companies
- DNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DIAX Finance
- DNA Health Care
- Exchange
- DIAX Nasdaq
- DNA Nasdaq
- Market Cap
- DIAX 516.0M
- DNA 466.4M
- IPO Year
- DIAX N/A
- DNA N/A
- Fundamental
- Price
- DIAX $14.31
- DNA $11.42
- Analyst Decision
- DIAX
- DNA Sell
- Analyst Count
- DIAX 0
- DNA 3
- Target Price
- DIAX N/A
- DNA $9.67
- AVG Volume (30 Days)
- DIAX 96.6K
- DNA 1.4M
- Earning Date
- DIAX 01-01-0001
- DNA 08-07-2025
- Dividend Yield
- DIAX 7.93%
- DNA N/A
- EPS Growth
- DIAX N/A
- DNA N/A
- EPS
- DIAX N/A
- DNA N/A
- Revenue
- DIAX N/A
- DNA $237,417,000.00
- Revenue This Year
- DIAX N/A
- DNA N/A
- Revenue Next Year
- DIAX N/A
- DNA $15.81
- P/E Ratio
- DIAX N/A
- DNA N/A
- Revenue Growth
- DIAX N/A
- DNA 13.76
- 52 Week Low
- DIAX $12.80
- DNA $5.00
- 52 Week High
- DIAX $15.12
- DNA $16.85
- Technical
- Relative Strength Index (RSI)
- DIAX 52.76
- DNA 64.12
- Support Level
- DIAX $13.63
- DNA $8.21
- Resistance Level
- DIAX $13.92
- DNA $10.02
- Average True Range (ATR)
- DIAX 0.12
- DNA 0.69
- MACD
- DIAX -0.00
- DNA 0.09
- Stochastic Oscillator
- DIAX 64.06
- DNA 84.19
About DIAX Nuveen Dow 30SM Dynamic Overwrite Fund of Beneficial Interest
Nuveen Dow 30sm Dynamic Overwrite Fund is a non-diversified closed-end management investment company. Its investment objective is to seek attractive total return with less volatility than the Dow Jones Industrial Average by investing in an equity portfolio that seeks to substantially replicate the price movements of the DJIA, as well as selling call options on 35%-75% of the notional value of the Fund's equity portfolio.
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.